IGH::FENDRR and specific KRAS mutations define a novel B-ALL molecular subtype with poor chemotherapy response

Sonja Bendig(Munich Leukemia Laboratory (Germany)), Lorenz Bastian(University Hospital Schleswig-Holstein), Thomas Beder(University Hospital Schleswig-Holstein), Johanna Horns(University Hospital Schleswig-Holstein), Emmanuelle Clappier(Centre National de la Recherche Scientifique), T. Leguay(Centre Hospitalier Universitaire de Bordeaux), Fabio D. Steffen(University Children's Hospital Zurich), Rathana Kim(Centre National de la Recherche Scientifique), Britta Kehden(University Hospital Schleswig-Holstein), Qingsong Gao(St. Jude Children's Research Hospital), Guranda Chitadze(Christian-Albrechts-Universität zu Kiel), Katharina Iben(University Hospital Schleswig-Holstein), Nadine Wolgast(University Hospital Schleswig-Holstein), Marie Passet(Centre National de la Recherche Scientifique), Hauke Busch(German Cancer Research Center), Leonardo Alves dos Santos(University Hospital Schleswig-Holstein), Loredana K. Cantoni(University Children's Hospital Zurich), Jean-Pierre Bourquin(University Children's Hospital Zurich), Charles G. Mullighan(St. Jude Children's Research Hospital), Axel Künstner(University of Lübeck), Monika Brüggemann(University Hospital Schleswig-Holstein), Ilaria Iacobucci(St. Jude Children's Research Hospital), Nicola Gökbuget(Goethe University Frankfurt), Nicolas Boissel(Université Paris Cité), Claudia D Baldus(University Hospital Schleswig-Holstein), Alina Hartmann(University Hospital Schleswig-Holstein), Wiebke Wessels(Children's Cancer Institute Australia), Beat Bornhäuser(University Children's Hospital Zurich)
Blood
March 27, 2026
10.1182/blood.2025031102
Cited by 0

Related Papers

Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1
|Journal of Clinical Investigation|2008|1.8k
HOXA genes are included in genetic and biologic networks defining human acute T-cell leukemia (T-ALL)
|Blood|2005|376
Down syndrome acute lymphoblastic leukemia, a highly heterogeneous disease in which aberrant expression of CRLF2 is associated with mutated JAK2: a report from the International BFM Study Group
|Blood|2009|347
Induction of autophagy-dependent necroptosis is required for childhood acute lymphoblastic leukemia cells to overcome glucocorticoid resistance
|Journal of Clinical Investigation|2010|311
<i>IKZF1</i><sup>plus</sup>Defines a New Minimal Residual Disease–Dependent Very-Poor Prognostic Profile in Pediatric B-Cell Precursor Acute Lymphoblastic Leukemia
|Journal of Clinical Oncology|2018|304